Development by UCLA-led research team works to keep blood sugar at normal levels
UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes.
The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.
Insulin is a hormone naturally produced in the pancreas. It helps the body regulate glucose, which is consumed through food and provides the body with energy.
Diabetes occurs when a person’s body does not naturally produce insulin (Type 1 diabetes), or does not efficiently use the insulin that is produced (Type 2). In either case, a regular dosage of insulin is prescribed to manage the disease, which affects more than 400 million people worldwide.
Generally, people who need to use insulin monitor their blood sugar levels with a glucose meter or continuous glucose monitoring system and then calculate their insulin dose accordingly. In addition, a regular carbohydrate intake is important to keep the blood sugar levels normal. Both of these requirements are necessarily subject to human error, which can have potentially devastating consequences.
An overdose of insulin can cause hypoglycemia, when blood sugar is too low. That could lead to seizures, coma, and in extreme cases, death.
As a safety check, the UCLA-led team has developed a type of “smart” insulin, called i-insulin, that can prevent blood sugar levels from dipping too low.
Inside the body, insulin acts as a “key” to help glucose get into cells from the bloodstream. When insulin attaches to a cell’s surface, it activates a protein inside the cell, called glucose transporter, which then makes its way to the cell’s surface. This molecule then brings the surrounding glucose from the blood into the cell.
The research team added an additional molecule to insulin to create the new smart insulin. This added molecule, called a glucose transporter inhibitor, chemically blocks the glucose transporter molecule that has come to the surface. Its presence doesn’t block all glucose from entering, nor does it permanently block the transporter molecules. Instead, it’s part of a dynamic process that depends on how many inhibitor and glucose molecules are present.
“Our new i-insulin works like a ‘smart’ key,” said the study’s principal investigator Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering. “The insulin lets glucose get into the cell, but the added inhibitor molecule prevents too much from going in when blood sugar is normal. This keeps blood sugar at normal levels and reduces the risk of hypoglycemia.”
“This i-insulin can also rapidly respond to high glucose levels,” added Jinqiang Wang, the study’s co-lead author and a postdoctoral researcher in Gu’s research group. “For example, after a meal, when glucose levels climb, the insulin level in the bloodstream also quickly increases, which helps normalize the glucose level.”
The UCLA-led research team tested the smart insulin on mice with Type 1 diabetes. The i-insulin controlled glucose levels within the normal range for up to 10 hours after a first injection. A second injection three hours later extended the protection from hypoglycemia.
“The next step is to further evaluate the long-term biocompatibility of the modified insulin system in an animal model before determining whether to move to clinical trials,” said co-author Dr. John Buse, a professor and director of the Diabetes Care Center at the University of North Carolina School of Medicine. “The vision, if realized, would be one of the most exciting advances in diabetes care.”
“The new insulin has the potential to be optimized for response times and how long it could last in the body before another dose would be required,” Gu said. “And it could be delivered in other methods, such as a skin patch with tiny needles, or in pills.”
The Latest on: Diabetes
[google_news title=”” keyword=”diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Diabetes
- Neighborhood walkability linked to risk of gestational diabeteson February 4, 2023 at 1:52 am
A new study by scientists in the Columbia University Mailman School of Public Health's Built Environment and Health Research Group finds that higher neighborhood walkability is associated with lower ...
- Projected rapid growth in diabetes disease burden and economic burden in China: a spatio-temporal study from 2020 to 2030on February 3, 2023 at 11:58 pm
Our study projects a significant growth of disease and economic burden of diabetes in China during 2020–2030, with strong spatial aggregation in northern Chinese regions. The increase in the economic ...
- Diabetes medication shortage explainedon February 3, 2023 at 3:42 pm
Recently, patients with diabetes have been experiencing a shortage with their medications ever since the drugs have become more popular for those looking to shed some pounds. Some celebrities have ...
- Diabetes patients struggle in Tennessee to find Ozempic amid unintended use for weight losson February 3, 2023 at 3:37 pm
A drug meant to improve blood sugar is being used for weight loss, and now some diabetes patients are struggling to find it.
- 15 Diabetes-Friendly Sandwiches to Make for Lunchon February 3, 2023 at 10:17 am
In this healthy chicken sandwich recipe, the avocado is mashed to create a healthy creamy spread. This variation of a classic sandwich uses mayonnaise, but not where you think! Mayo is brushed on the ...
- A difference in economic status should not be a barrier to diabetes care in Minnesotaon February 3, 2023 at 8:36 am
As the rising rates of diabetes is closely linked to the economic status of people, the state should focus on improving living conditions, providing more job opportunities, and increasing access to ...
- Longer Diabetes Duration Links With Increased Heart Failureon February 3, 2023 at 7:37 am
Prospective data from nearly 24,000 people with diabetes showed that longer diabetes duration significantly linked with an increased heart failure incidence.
- Could vitamins help you avoid diabetes, heart disease? Here's what a Texas State researcher foundon February 3, 2023 at 5:00 am
The 30-year study found an association between B6, B12 and folate and lower risk for metabolic syndrome. Here's what that means.
- Lilly’s Type 2 diabetes drug Mounjaro didn’t sell enough to impress, analysts sayon February 3, 2023 at 4:10 am
The new Type 2 diabetes treatment may be in high demand, but sales came in far below Wall Street’s expectations.
- Eli Lilly's weak diabetes drugs sales cloud 2023 profit forecaston February 2, 2023 at 11:07 am
Eli Lilly and Co missed Wall Street estimates for fourth-quarter sales of both the closely-watched new type 2 diabetes drug Mounjaro and its blockbuster treatment for the condition, overshadowing a ...
via Bing News